ZIKAlliance Pregnant Women Cohort
Studying Zika virus disease
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- University of Heidelberg Medical Center
- Principal Investigator
- Thomas JänischUniversity Hospital Heidelberg
- Enrollment
- 3852 enrolled
- Eligibility
- 16-45 years · FEMALE
- Timeline
- 2017 – 2021
Study locations (14)
- Sosecali Ltd. (SOSE), Guaqui, Bolivia
- INSERM, Santa Cruz, Bolivia
- Federal University of Bahia (UFB), Bahia, Brazil
- Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
- Federal University of Goias, Goiás, Brazil
- Fundacao Oswaldo Cruz (FIOCRUZ), Recife, Brazil
- Fundacao Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil
- University of Sao Paulo, São Paulo, Brazil
- Industrial University of Santander (UIS), Bucaramanga, Colombia
- Pedro Kouri Institute (IPK), Havana, Cuba
- INSERM, Pointe-à-Pitre, Guadeloupe
- IMSS Mexico (IMSS), Guadalajara, Mexico
- National Institute of Public Health (INSP), Mérida, Mexico
- Universidad de Carabobo / UMC Groningen (UMCG), Valencia, Venezuela
Collaborators
European Union · ZIKAlliance · Oswaldo Cruz Foundation · University of Sao Paulo · London School of Hygiene and Tropical Medicine · Federal University of Bahia · Universidade Federal de Goias · University Medical Center Groningen · University of Carabobo · Universidad Industrial de Santander · Sosecali Hospital, Guyaquil · Instituto de Medicina Tropical "Pedro Kourí (IPK), Cuba · Mexican National Institute of Public Health · Instituto Mexicano del Seguro Social · Institut National de la Santé Et de la Recherche Médicale, France · Erasmus Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03188731 on ClinicalTrials.govOther trials for Zika virus disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT04398901Neurodevelopmental Outcomes in ZIKV-Exposed ChildrenChildren's National Research Institute
- ACTIVE NOT RECRUITINGPHASE3NCT03037164INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsCerus Corporation
- RECRUITINGNCT01386424Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsNational Institute of Allergy and Infectious Diseases (NIAID)